ADCT
ADC Therapeutics SA
1.30$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 4,743.8% | 10,358.4% | 4,595.6% | – | 4.1% | 1.6% | 3.6% | 8.4% | 9.4% | |
| -4,643.8% | -10,258.4% | 100.0% | – | 95.9% | 98.4% | 96.4% | 91.6% | 90.6% | |
| 4,743.8% | 10,378.3% | 4,595.6% | – | 465.8% | 88.8% | 182.8% | 154.8% | 127.8% | |
| 432.9% | 754.6% | 606.9% | – | 210.7% | 51.3% | 104.8% | 91.0% | 44.9% | |
| 5,184.3% | 11,147.5% | 5,202.5% | – | 867.5% | 157.2% | 335.0% | 276.0% | 223.8% | |
| -5,084.3% | -11,047.5% | -5,102.5% | – | -771.6% | -58.8% | -238.6% | -184.4% | -133.2% | |
| 148.7% | 287.9% | 6.7% | – | 54.1% | 17.5% | 66.6% | 70.9% | 63.5% | |
| -4,981.4% | -10,778.2% | -4,953.1% | – | -741.5% | -74.7% | -288.9% | -222.6% | -175.5% | |
| 2.7% | 19.6% | 24.9% | – | -63.3% | 0.1% | 56.2% | 0.2% | -0.2% | |
| -4,984.0% | -10,797.9% | -4,977.9% | – | -678.2% | -74.9% | -345.1% | -222.8% | -175.3% | |
| -5,065.4% | -10,733.2% | -4,876.1% | – | -679.7% | -51.3% | -209.6% | -144.9% | -109.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.